GXI GR

Gerresheimer AG

Healthcare


Presented:12/18/2023
Price:€88.60
Cap:$3.41B
Current Price:€83.10
Cap:$3.20B

Presented

Date12/18/2023
Price€88.60
Market Cap$3.41B
Ent Value$5.72B
P/E Ratio26.92x
Book Value€41.39
Div Yield1.41%
Shares O/S34.54M
Ave Daily Vol129,146
Short IntN/A

Current

Price€83.10
Market Cap$3.20B
Gerresheimer AG manufactures and supplies glass and plastic products for the pharmaceutical and healthcare industry. It operates through the following segments: Plastic and Devices and Primary Packaging Glass. The Plastic and Devices segment includes insulin pens, inhalers and refillable syringes as well as diagnostics and medical technology products such as skin-prick aids and test systems and pharmaceutical plastic containers for liquid and solid medicines. The Primary Packaging Glass segment refers to the primary packaging made of glass of medicines and cosmetics such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, and special containers for food and drinks. The company was founded in 1864 and is headquartered in Duesseldorf, Germany.

Publicly traded companies mentioned herein: Gerresheimer AG (GXI GR), Stevanato Group SpA (STVN), West Pharmaceutical Services Inc (WST)

Highlights

The presenter is long shares of Gerresheimer AG (GXI GR), a German pharmaceutical packaging company for drugs (including GLP-1s) and cosmetics. He highlights GXI’s major discount vs. peers as one reason for his bullish view and believes the connection to the GLP-1 industry can be a catalyst for the company’s growth going forward.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.